Tuesday, March 24, 2020 5:46:30 PM
Shares of Onconova Therapeutics, Inc. are trading higher in Tuesday's after-hours market, after the company said it completed enrolling patients in a Phase 3 trial and reported higher net revenue for 2019 over the previous year.
At 5:07 p.m. EDT, Onconova shares had risen 17.78% to trade at 43 cents. Volume in the after-hours session topped 3.7 million shares.
The company's stock finished the day's regular-trading session with a 15.58% gain, closing at 36 cents.
Onconova said it had completed enrolling 360 patients in the Phase 3 Inspire trial, which is designed to test the efficacy and safety of IV rigosertib in certain patients suffering from myelodysplastic syndromes, a type of cancer that can disrupt the production of blood cells.
Steven M. Fruchtman, the company's president and chief executive, said, "We are also pleased about the progress of our plans for additional investigator-initiated studies - including the Phase 1/2a study of rigosertib plus nivolumab for the treatment of Stage IV KRAS mutated lung adenocarcinoma. We anticipate the first patient to be entered onto the trial once the COVID-19 environment improves sufficiently."
The company reported 2019 revenue of $2,183,000, above the 2018 figure of $1,228,000.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
March 24, 2020 17:32 ET (21:32 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM